← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cairn Biosciences, Inc.
San Francisco, CA
$6,115,055
Total funding
7
Grants
Funding over time
peak $2.7M · FY2016–21$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,115,055 · 7
By mechanism
R44$2,323,695 · 2
N44$1,499,999 · 1
N01$1,499,968 · 1
N43$791,393 · 3
Investigators at Cairn Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF MULTIPLEXED HIGH-CONTENT ASSAY TO MEASURE CELLULAR STRESS MECHANISMS FOR PREDICTIVE TOXICOLOGY STUDIES$1,499,999
N44 · FY2016 · DA
A microfluidic-enabled SmartPlate for precision culture, control and monitoring of living cells. NAICS 5417715 PSC AN12 Contractor DUNS 078744267$1,499,968
N01 · FY2018 · DA
Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding$1,178,386
R44 · FY2018 · TR
Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding$821,559
R44 · FY2019 · TR
A MICROFLUIDIC AND MACHINE LEARNING-ENABLED SMARTLAB FOR AUTONOMOUS REMOTE EXECUTION AND ITERATION OF MULTISCALE LIVE CELL ASSAYS FOR DRUG DISCOVERY$331,500
N43 · FY2021 · DA
High-throughput profiling of compound abuse liabilities and identification of addiction-related drug targets using an iPSC-enabled platform$323,750
R44 · FY2019 · DA
IGF::OT::IGF A MULTIFUNCTIONAL, REUSABLE AND AUTOMATED MICROFLUIDIC SMART PLATE FOR HIGH THROUGHPUT LIVE CELL ASSAYS$230,000
N43 · FY2016 · DA
IGF::OT::IGF MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS$229,893
N43 · FY2016 · DA